Whats Hot in Seattle Biotech

▤ Summary

To highlight the strengths of Seattles life-science community, as well as its challenges, look no further than two major deals that kicked off 2018.The first was Microsoft’s agreement to pursue an ambitious multi-disease diagnostic test with Fred Hutch spinout Adaptive Biotechnologies.The question looms even larger in light of the second major deal, which saw another anchor of Seattle’s biotech community, Juno Therapeutics, snapped up by an outside buyer.Juno will remain a standalone subsidiary—but what does its acquisition portend for Seattle’s biotechnology community?Can other major companies emerge from the local immunotherapy hub—one of the world’s most dynamic—to call their own shots?

▦ Linked Companies